The Role of Specialty Pharmacy During New Product Launches

Description: When a manufacturer brings a new rare, orphan or oncology product to market, there are hurdles that must be overcome before patients can begin what may be a long-awaited therapy. Collaborating with a skilled specialty pharmacy can minimize therapy disruptions.  Learning Objectives: To discuss the role of specialty pharmacy during the launch of new to market therapies Focus on how Biologics (and MID as part of SPS) supported MFR through the launch of a new therapeutic agent. Describe collaboration between Biologics and MFR to improve on launch preparation and messaging to prescribers. To discuss the payer challenges commonly seen with new therapies. Speak to how Biologics managed payer challenges and navigates complexities that arise post-launch. Medication not on formulary. Need/use of bridge programs, quick start, financial assistance. Patient experience, pain points, and unacceptable costs. Demonstrate how Biologics closes these gaps. To highlight the role of specialty pharmacy sales with product launch and support Focus on the specialty pharmacy liaison role and provider collaboration. Payer gaps and wrap-around service. Support and navigation with delays.